ILAE Treatment Guidelines: Evidence‐based Analysis of Antiepileptic Drug Efficacy and Effectiveness as Initial Monotherapy for Epileptic Seizures and Syndromes

Summary:  Purpose: To assess which antiepileptic medications (AEDs) have the best evidence for long‐term efficacy or effectiveness as initial monotherapy for patients with newly diagnosed or untreated epilepsy.

[1]  B. Bourgeois,et al.  Topiramate in patients with juvenile myoclonic epilepsy. , 2005, Archives of neurology.

[2]  D. Naritoku,et al.  Randomized dose‐controlled study of topiramate as first‐line therapy in epilepsy , 2005, Acta neurologica Scandinavica.

[3]  B. Uthman,et al.  New onset geriatric epilepsy , 2005, Neurology.

[4]  A. Marson,et al.  A systematic review of treatment of typical absence seizures in children and adolescents with ethosuximide, sodium valproate or lamotrigine , 2005, Seizure.

[5]  Marco Carotenuto,et al.  Lamotrigine versus Valproic Acid as First‐line Monotherapy in Newly Diagnosed Typical Absence Seizures: An Open‐label, Randomized, Parallel‐group Study , 2004, Epilepsia.

[6]  B. Bourgeois,et al.  Choosing Antiepileptic Drugs for Developmentally Normal Children With Specific Epilepsy Syndromes and Behavioral Disorders , 2004, Journal of child neurology.

[7]  B. Bourgeois,et al.  Efficacy and Tolerability of the New Antiepileptic Drugs, I: Treatment of New‐Onset Epilepsy: Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society , 2004, Epilepsia.

[8]  B. Bourgeois,et al.  CME Efficacy and tolerability of the new antiepileptic drugs I : Treatment of new onset epilepsy Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society , 2004 .

[9]  J. Wheless,et al.  Topiramate, Carbamazepine, and Valproate Monotherapy: Double-Blind Comparison in Children With Newly Diagnosed Epilepsy , 2004, Journal of child neurology.

[10]  K. Y. Chan,et al.  Benign childhood epilepsy with centrotemporal spikes: a study of 50 Chinese children , 2003, Brain and Development.

[11]  L. Bello-Espinosa,et al.  Levetiracetam for benign epilepsy of childhood with centrotemporal spikes—three cases , 2003, Seizure.

[12]  P. Camfield,et al.  Childhood Epilepsy: What Is the Evidence for What We Think and What We Do? , 2003, Journal of child neurology.

[13]  R. Mattson,et al.  Topiramate, carbamazepine and valproate monotherapy: double‐blind comparison in newly diagnosed epilepsy , 2003, Acta neurologica Scandinavica.

[14]  G. Pledger,et al.  A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy , 2003, Neurology.

[15]  Catrin Tudur Smith,et al.  Carbamazepine versus phenobarbitone monotherapy for epilepsy. , 2003, The Cochrane database of systematic reviews.

[16]  M. Brodie,et al.  Gabapentin versus Lamotrigine Monotherapy: A Double‐blind Comparison in Newly Diagnosed Epilepsy , 2002, Epilepsia.

[17]  J. Armijo,et al.  [Evidence based treatment of epilepsy]. , 2002, Revista de neurologia.

[18]  J. Whitehead,et al.  Remacemide versus carbamazepine in newly diagnosed epilepsy , 2002, Epilepsy & Behavior.

[19]  Helen Clough,et al.  Carbamazepine versus Valproate Monotherapy for Epilepsy: A Meta‐analysis , 2002, Epilepsia.

[20]  P. Levy.  Economic Evaluation of Antiepileptic Drug Therapy: A Methodologic Review , 2002, Epilepsia.

[21]  J. Whitehead,et al.  Efficacy and Safety of Remacemide versus Carbamazepine in Newly Diagnosed Epilepsy: Comparison by Sequential Analysis , 2002, Epilepsy & Behavior.

[22]  Kenneth F Schulz,et al.  Blinding in randomised trials: hiding who got what , 2002, The Lancet.

[23]  Kenneth F Schulz,et al.  Allocation concealment in randomised trials: defending against deciphering , 2002, The Lancet.

[24]  A. Marson,et al.  Carbamazepine versus phenytoin monotherapy for epilepsy. , 2002, The Cochrane database of systematic reviews.

[25]  A G Marson,et al.  Phenytoin versus valproate monotherapy for partial onset seizures and generalized onset tonic-clonic seizures. , 2001, The Cochrane database of systematic reviews.

[26]  A. Marson,et al.  Clinical guidelines for the management of epilepsy in adults with an intellectual disability , 2001, Seizure.

[27]  G. Capovilla,et al.  A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy , 2001, Epilepsy Research.

[28]  E. Carrazana,et al.  Exacerbation of juvenile myoclonic epilepsy with lamotrigine , 2001, Neurology.

[29]  S. Evers,et al.  Estimating the Costs of Epilepsy: An International Comparison of Epilepsy Cost Studies , 2001, Epilepsia.

[30]  R. Estok,et al.  Management of newly diagnosed patients with epilepsy: a systematic review of the literature. , 2001, Evidence report/technology assessment.

[31]  Catrin Tudur Smith,et al.  Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalized onset tonic-clonic seizures. , 2001, The Cochrane database of systematic reviews.

[32]  C. Y. Liu,et al.  Patients' versus caregivers' report of poor memory in relation to dementia and tested abilities. , 2000, Neurology.

[33]  A. Marson,et al.  Quality‐of‐Life and Behavioral Outcome Measures in Randomized Controlled Trials of Antiepileptic Drugs: A Systematic Review of Methodology and Reporting Standards , 2000, Epilepsia.

[34]  K. Tyler,et al.  The Goltz–Ferrier debates and the triumph of cerebral localizationalist theory , 2000, Neurology.

[35]  T. Bast,et al.  Sulthiame as Monotherapy in Children with Benign Childhood Epilepsy with Centrotemporal Spikes: A 6‐Month Randomized, Double‐Blind, Placebo‐Controlled Study , 2000, Epilepsia.

[36]  Masato Matsuura,et al.  Indication for Anterior Temporal Lobectomy in Patients with Temporal Lobe Epilepsy and Psychopathology , 2000, Epilepsia.

[37]  A. Husain,et al.  Characteristics of valproic acid resistant juvenile myoclonic epilepsy , 2000, Seizure.

[38]  T. Barron,et al.  Lamotrigine monotherapy in children. , 2000, Pediatric neurology.

[39]  P. Genton.  When antiepileptic drugs aggravate epilepsy , 2000, Brain and Development.

[40]  M. Brodie,et al.  Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy , 1999, Epilepsy Research.

[41]  D. Chadwick.  Safety and efficacy of vigabatrin and carbamazepine in ne wly diagnosed epilepsy: a multicentre randomised double-blind study , 1999, The Lancet.

[42]  G. Holmes,et al.  Lamictal (Lamotrigine) Monotherapy for Typical Absence Seizures in Children , 1999, Epilepsia.

[43]  M. Park,et al.  Lamotrigine Monotherapy in Newly Diagnosed Untreated Epilepsy: A Double‐Blind Comparison with Phenytoin , 1999, Epilepsia.

[44]  N. Zamponi,et al.  Open comparative long-term study of vigabatrin vs carbamazepine in newly diagnosed partial seizures in children. , 1999, Archives of neurology.

[45]  T. Tomson,et al.  Valproate monotherapy in juvenile myoclonic epilepsy: dose-related effects on electroencephalographic and other neurophysiologic tests. , 1999, Therapeutic drug monitoring.

[46]  D. Chadwick.  Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group. , 1999, Lancet.

[47]  Practice Parameter: Management Issues for Women with Epilepsy (Summary Statement) , 1998, Epilepsia.

[48]  D. Chadwick,et al.  A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures , 1998, Neurology.

[49]  L. Wilkins.  Consensus statements , 1998, Neurology.

[50]  A. Marson,et al.  Neuropsychological Outcomes in Randomized Controlled Trials of Antiepileptic Drugs: A Systematic Review of Methodology and Reporting Standards , 1998, Epilepsia.

[51]  Clobazam Has Equivalent Efficacy to Carbamazepine and Phenytoin as Monotherapy for Childhood Epilepsy , 1998, Epilepsia.

[52]  D. Chadwick,et al.  Considerations on Designing Clinical Trials to Evaluate the Place of New Antiepileptic Drugs in the Treatment of Newly Diagnosed and Chronic Patients with Epilepsy , 1998, Epilepsia.

[53]  I. Chan,et al.  Exact tests of equivalence and efficacy with a non-zero lower bound for comparative studies. , 1998, Statistics in medicine.

[54]  T. Tomson,et al.  Valproate as monotherapy for juvenile myoclonic epilepsy: dose-effect study. , 1998, Therapeutic drug monitoring.

[55]  P. Genton,et al.  Antiepileptic Drug‐Induced Worsening of Seizures in Children , 1998, Epilepsia.

[56]  D. Ataklı,et al.  Misdiagnosis and treatment in juvenile myoclonic epilepsy , 1998, Seizure.

[57]  B. Engelsen,et al.  Juvenile myoclonic epilepsy: clinical characteristics, treatment and prognosis in a Norwegian population of patients , 1998, Seizure.

[58]  Anthony L. Johnson,et al.  Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India , 1998, The Lancet.

[59]  G. Avanzini,et al.  Antiepileptic Drugs as a Cause of Worsening Seizures , 1998, Epilepsia.

[60]  B. Bourgeois.  Gabapentin (Neurontin) monotherapy in children with benign childhood epilepsy with centrotemporal spikes (BECTS): a 36-week, double-blind, placebo-controlled study , 1998 .

[61]  B. Wilder.  Consensus statements: Medical management of epilepsy , 1998 .

[62]  Body Mass Index in Growth Hormone Deficient Children before and during Growth Hormone Treatment , 1997, Hormone Research in Paediatrics.

[63]  D. Chadwick.  Monotherapy Clinical Trials of New Antiepileptie Drugs: Design, Indications, and Controversies , 1997, Epilepsia.

[64]  N. Fejerman,et al.  A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy 1 This work was carried out on behalf of the International Pediatric Oxcarbazepine/Phenytoin Trial Group (Appendix A). 1 , 1997, Epilepsy Research.

[65]  S. Kochen,et al.  A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy 1 This study was carried out on behalf of the International Adult Oxcarbazepine/Phenytoin Trial Group (see Appendix A). 1 , 1997, Epilepsy Research.

[66]  Thoru Yamada,et al.  The effectiveness of clonazepam on the rolandic discharges , 1997, Brain and Development.

[67]  R. Ramsay,et al.  Tonic-clonic seizures: a systematic review of antiepilepsy drug efficacy and safety. , 1997, Clinical therapeutics.

[68]  B. Steinhoff,et al.  A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy 1 This work was carried out on behalf of the International Oxcarbazepine/Valproate Trial Group (see Appendix A). 1 , 1997, Epilepsy Research.

[69]  J. Ebersole,et al.  Gabapentin in Naive Childhood Absence Epilepsy: Results From Two Double-Blind, Placebo-Controlled, Multicenter Studies , 1996, Journal of child neurology.

[70]  G. Regesta,et al.  Vigabatrin vs. carbamazepine monotherapy in newly diagnosed focal epilepsy: a randomized response conditional cross-over study , 1996, Epilepsy Research.

[71]  J. Cramer,et al.  Effect of valproate on cognitive functioning. Comparison with carbamazepine. The Department of Veterans Affairs Epilepsy Cooperative Study 264 Group. , 1996, Archives of neurology.

[72]  N. Thilothammal,et al.  Comparison of phenobarbitone, phenytoin with sodium valproate: randomized, double-blind study. , 1996, Indian pediatrics.

[73]  N. Buchanan,et al.  The use of lamotrigine in juvenile myoclonic epilepsy , 1996, Seizure.

[74]  E. Hughes,et al.  Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy , 1996, The Lancet.

[75]  M. Dam,et al.  A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy , 1996, Epilepsy Research.

[76]  Yung-Jung Chen,et al.  Comparison of Antiepileptic Drugs on Cognitive Function in Newly Diagnosed Epileptic Children: A Psychometric and Neurophysiological Study , 1996, Epilepsia.

[77]  M. Jokelainen,et al.  Comparing the Cognitive Effects of Phenytoin and Carbamazepine in Long‐Term Monotherapy: A Two‐Year Follow‐Up , 1995, Epilepsia.

[78]  P. Riekkinen,et al.  Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study. , 1995, Archives of neurology.

[79]  M. Brodie,et al.  Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy , 1995, The Lancet.

[80]  N. Buchanan,et al.  Juvenile myoclonic epilepsy: diagnosis, management and outcome , 1995, The Medical journal of Australia.

[81]  C. Verity,et al.  A MULTICENTRE COMPARATIVE TRIAL OF SODIUM VALPROATE AND CARBAMAZEPINE IN PAEDIATRIC EPILEPSY , 1995, Developmental medicine and child neurology.

[82]  R. J. Hayes,et al.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.

[83]  R. Elwes,et al.  Phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed adult epilepsy: a randomised comparative monotherapy trial. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[84]  M. Brodie,et al.  Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group. , 1995, Lancet.

[85]  A. Richens,et al.  A multicentre comparative trial of sodium valproate and carbamazepine in adult onset epilepsy. Adult EPITEG Collaborative Group. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[86]  R. Tallis,et al.  Impact of Valproate and Phenytoin on Cognitive Function in Elderly Patients: Results of a Single‐Blind Randomized Comparative Study , 1994, Epilepsia.

[87]  D. Stein,et al.  Negative and depressive symptoms in suicidal schizophrenics , 1994, Acta psychiatrica Scandinavica.

[88]  M. Jokelainen,et al.  Effects of phenytoin and carbamazepine on cognitive functions in newly diagnosed epileptic patients , 1994, Acta neurologica Scandinavica.

[89]  T. Kurashige,et al.  Proposal for Revised Classification of Epilepsies and Epileptic Syndromes , 1989, No to hattatsu = Brain and development.

[90]  Josemir W Sander,et al.  Antiepileptic drug treatment in a community health care setting in northern Ecuador: a prospective 12-month assessment , 1993, Epilepsy Research.

[91]  I. Berg,et al.  PSYCHIATRIC ASPECTS OF EPILEPSY IN CHILDHOOD TREATED WITH CARBAMAZEPINE, PHENYTOIN OR SODIUM VALPROATE: A RANDOM TRIAL , 1993, Developmental medicine and child neurology.

[92]  J. Cramer,et al.  A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. , 1992, The New England journal of medicine.

[93]  T. Halonen,et al.  Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up , 1992, Epilepsy Research.

[94]  G. Holmes,et al.  Efficacy and safety of valproic acid versus phenytoin as sole therapy for newly diagnosed primary generalized tonic-clonic seizures , 1992 .

[95]  P. Rastogi,et al.  Comparison of sodium valproate and phenytoin as single drug treatment in generalised and partial epilepsy. , 1991, The Journal of the Association of Physicians of India.

[96]  I. Berg,et al.  Cognitive Impairment in New Cases of Epilepsy Randomly Assigned to Carbamazepine, Phenytoin and Sodium Valproate , 1991, Developmental medicine and child neurology.

[97]  J. W. A. S. Sander,et al.  Comprehensive primary health care antiepileptic drug treatment programme in rural and semi-urban Kenya , 1991, The Lancet.

[98]  J. R. Hughes,et al.  Advances in epileptology , 1990 .

[99]  C. R. Mehta,et al.  StatXact : a statistical package for exact non-parametric inference, Cytel Software Corporation, Cambridge, MA, USA , 1990 .

[100]  M. Field,et al.  Clinical practice guidelines : directions for a new program , 1990 .

[101]  J. Dean,et al.  Juvenile Myoclonic Epilepsy: Long‐Term Response to Therapy , 1989, Epilepsia.

[102]  C. Panayiotopoulos,et al.  Clonazepam in Juvenile Myoclonic Epilepsy , 1989, Epilepsia.

[103]  P. Patsalos,et al.  Oxcarbazepine: a new drug in the management of intractable trigeminal neuralgia. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[104]  Y. Løyning,et al.  A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy , 1989, Epilepsy Research.

[105]  Jorge Eslava‐Cobos,et al.  Experience with the International League Against Epilepsy Proposals for Classification of Epileptic Seizures and the Epilepsies and Epileptic Syndromes in a Pediatric Outpatient Epilepsy Clinic , 1989, Epilepsia.

[106]  W. Dodson,et al.  Carbamazepine Efficacy and Utilization in Children , 1987, Epilepsia.

[107]  B. Bourgeois,et al.  Monotherapy with Valproate in Primary Generalized Epilepsies , 1987, Epilepsia.

[108]  W. Mitchell,et al.  Carbamazepine Versus Phenobarbital for Partial Onset Seizures in Children , 1987, Epilepsia.

[109]  R. Young,et al.  A Randomized, Double-Blind, Crossover Study of Phenobarbital and Mephobarbital , 1986, Journal of child neurology.

[110]  J. Cramer,et al.  Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. , 1985, The New England journal of medicine.

[111]  R. Kenny,et al.  A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy. , 1985, Journal of neurology, neurosurgery, and psychiatry.

[112]  D. Turnbull,et al.  Which drug for the adult epileptic patient: phenytoin or valproate? , 1985, British medical journal.

[113]  A. Delgado-Escueta,et al.  Juvenile myoclonic epilepsy of Janz , 1984, Neurology.

[114]  M. Okajima,et al.  Quantitative and genetic features of epidermal ridge minutiae on the palm of twins. , 1984, Human heredity.

[115]  J. Dartigues,et al.  [Efficacy of sodium valproate in partial epilepsy. Crossed study of valproate and carbamazepine]. , 1984, Revue neurologique.

[116]  W. Shields,et al.  Myoclonic, atonic, and absence seizures following institution of carbamazepine therapy in children , 1983, Neurology.

[117]  D. Janz,et al.  [Relapse prognosis following reduction of drugs in epilepsy treatment]. , 1983, Der Nervenarzt.

[118]  B. Wilder,et al.  A double‐blind study comparing carbamazepine with phenytoin as initial seizure therapy in adults , 1983, Neurology.

[119]  O. Dulac,et al.  [Monotherapy with clobazam in epilepsies in children]. , 1983, Presse medicale.

[120]  F. Gibberd,et al.  A comparison of phenytoin and pheneturide in patients with epilepsy: a double-blind cross-over trial , 1982, Journal of neurology, neurosurgery, and psychiatry.

[121]  J. Parnas,et al.  Controlled Trials in Epilepsy: A Review , 1982, Epilepsia.

[122]  N. Callaghan,et al.  Comparative Study of Ethosuximide and Sodium Valproate in the Treatment of Typical Absence Seizures (Petit Mal) , 1982, Developmental medicine and child neurology.

[123]  B G White,et al.  Valproic acid versus ethosuximide in the treatment of absence seizures , 1982, Neurology.

[124]  D. Turnbull,et al.  A comparison of phenytoin and valproate in previously untreated adult epileptic patients. , 1982, Journal of neurology, neurosurgery, and psychiatry.

[125]  P. Joensen,et al.  Clonazepam (Rivotril®) and Carbamazepine (Tegretol®) in Psychomotor Epilepsy: A Randomized Multicenter Trial , 1981, Epilepsia.

[126]  P. Kellaway,et al.  Proposal for Revised Clinical and Electroencephalographic Classification of Epileptic Seizures , 1981, Epilepsia.

[127]  R. Shakir,et al.  Comparison of Sodium Valproate and Phenytoin as Single Drug Treatment in Epilepsy , 1981, Epilepsia.

[128]  E. Reynolds.  Antiepileptic Therapy: Advances in Drug Monitoring , 1980 .

[129]  G. Mathern,et al.  Epilepsia , 1991, NEURO FUNDAMENTAL.

[130]  E. Somerfeld-Ziskind,et al.  EFFECT OF PHENOBARBITAL ON THE MENTALITY OF EPILEPTIC PATIENTS , 1940 .